The “Spider-Man” offshoot (and second sequel to “Venom”) was lackluster in theaters compared to expectations (it did 73 million domestic/163 million worldwide). But with an 80 million production cost, it still has a shot of making a profit from post-theatrical returns.
Of note is that again Sony, despite the quick burnout of “Morbius” in theaters, went with a 45 days+ window. That is less of a wait than “Uncharted” or “Spider-Man: No Way Home” (5.99). Their patience has had its awards. Not only is “Uncharted” sustaining a long and elevated run, “No Way” also remains on the chart more than two months after its initial home release.
The three Sony films